Publications dans lesquelles il/elle collabore avec FERNANDO ARRIBAS YNSAURRIAGA (27)

2023

  1. Differences in clinical outcomes, health care resource utilization and costs in heart failure patients according to left ventricular ejection fraction

    Revista Espanola de Cardiologia, Vol. 76, Núm. 11, pp. 862-871

  2. Triple vasodilator therapy in pulmonary arterial hypertension associated with congenital heart disease

    Heart

  3. Twenty-four hour ambulatory blood pressure monitoring in patients with stable heart failure. Prevalence and associated factors

    Revista Espanola de Cardiologia, Vol. 76, Núm. 11, pp. 852-861

2022

  1. Clinical Utility of HeartLogic, a Multiparametric Telemonitoring System, in Heart Failure

    Cardiac Failure Review, Vol. 8

  2. Primary vs. Secondary Heart Failure Diagnosis: Differences in Clinical Outcomes, Healthcare Resource Utilization and Cost

    Frontiers in Cardiovascular Medicine, Vol. 9

  3. Rationale and Protocol of the Multimodality Evaluation of Antibody-Mediated Injury in Heart Transplantation (LEONE-HT) Observational Cross-Sectional Study

    Methods and Protocols, Vol. 5, Núm. 5

  4. Remote heart failure management using the HeartLogic algorithm. RE-HEART registry

    Revista Espanola de Cardiologia, Vol. 75, Núm. 9, pp. 710-717

  5. Response by Caravaca Pérez et al to Letter Regarding Article, "potential Role of Natriuretic Response to Furosemide Stress Test during Acute Heart Failure"

    Circulation: Heart Failure

2021

  1. Clinical relevance of adding intravascular ultrasound to coronary angiography for the diagnosis of extrinsic left main coronary artery compression by a pulmonary artery aneurysm in pulmonary hypertension

    Catheterization and Cardiovascular Interventions, Vol. 98, Núm. 4, pp. 691-700

  2. Electrocardiogram Changes in the Spectrum of TTNtv Dilated Cardiomyopathy: Accuracy and Predictive Value of a New Index for LV-Changes Identification

    Heart Lung and Circulation, Vol. 30, Núm. 10, pp. 1487-1495

  3. Impact of late-onset cytomegalovirus infection in the development of cardiac allograft vasculopathy in heart transplant recipients

    Transplant Infectious Disease, Vol. 23, Núm. 2

  4. Potential Role of Natriuretic Response to Furosemide Stress Test during Acute Heart Failure

    Circulation: Heart Failure, Vol. 14, Núm. 6, pp. E008166

  5. Selective segmental pulmonary angiography: Anatomical, technical and safety aspects of a must-learn technique in times of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension

    Journal of Clinical Medicine, Vol. 10, Núm. 15

2020

  1. A new mutation affecting the converter region of the beta-myosin heavy chain related to hypertrophic cardiomyopathy with poor prognosis

    Revista Espanola de Cardiologia, Vol. 73, Núm. 2, pp. 180-183

  2. First experience in Spain of cardiac contractility modulation. A new alternative for patients with heart failure

    Revista Espanola de Cardiologia, Vol. 73, Núm. 10, pp. 855-857

  3. Heart Transplantation in a Distant Island Population: Accessibility and Outcomes in Patients From the Canary Islands Transplanted in Madrid

    Transplantation, Vol. 104, Núm. 2, pp. 223-226

  4. Heart transplant during the COVID-19 pandemic: follow-up organization and characteristics of infected patients

    Revista Espanola de Cardiologia, Vol. 73, Núm. 12, pp. 1077-1080

  5. Influence of long-standing pulmonary arterial hypertension and its severity on pulmonary artery aneurysm development

    Heart and Vessels, Vol. 35, Núm. 9, pp. 1290-1298

  6. Levosimendan as bridge to transplant in patients with advanced heart failure

    Revista Espanola de Cardiologia, Vol. 73, Núm. 5, pp. 422-424

  7. Truncating titin variants in dilated cardiomyopathy: not only LVEF recovery, but also maintenance

    Revista Espanola de Cardiologia, Vol. 73, Núm. 7, pp. 589-592